Results 241 to 250 of about 146,147 (346)
Postsynaptic α1- and α2-Adrenergic Mechanisms in Coronary Vasoconstriction
Da Guang Chen+3 more
openalex +1 more source
Abstract Background Sedation in horses is typically achieved using alpha‐2 adrenoceptor agonists, although their use is associated with multiple side effects. A peripheral alpha‐2 adrenoceptor antagonist, vatinoxan, can alleviate many of these. Objectives To evaluate the effects of vatinoxan infusion on gastrointestinal motility, sedation, and ...
Bartlomiej Obrochta+7 more
wiley +1 more source
Astrocyte-driven vasoconstriction impairs glymphatic clearance in a human tauopathy-on-chip model. [PDF]
Park R, Peng Y, Yslas AR, Lee E.
europepmc +1 more source
Systemic sclerosis (SSc) is a rare autoimmune disease, and lung complications (ILD) are the main cause of death. This study compared SSc patients with and without lung disease to healthy volunteers. We found increased inflammation, specific proteins, and higher triglyceride levels linked to lung disease progression. These findings suggest triglycerides
Selena Bouffette+16 more
wiley +1 more source
Evidence of myogenic vasoconstriction in human bone vasculature. [PDF]
Draghici AE, Ely MR, Hamner JW.
europepmc +1 more source
Reflex alpha-adrenergic coronary vasoconstriction during hindlimb static exercise in dogs.
R. Aung-Din+2 more
openalex +1 more source
Abstract Objectives/Background Although nimodipine is commonly used to treat reversible cerebral vasoconstriction syndrome (RCVS), its disease‐modifying effects are not yet understood. We prospectively investigated the effect of nimodipine and treatment initiation timing on the prevention of worsened vasoconstriction in patients with angiogram‐proven ...
Soohyun Cho, Minjung Seong, Mi Ji Lee
wiley +1 more source
Calcium Signaling Dynamics in Vascular Cells and Their Dysregulation in Vascular Disease. [PDF]
Dai C, Khalil RA.
europepmc +1 more source